Zobrazeno 1 - 10
of 55
pro vyhledávání: '"I. De la Morena"'
Autor:
M. E. De La Morena-Barrio, J. Pagan, A. Miñano, V. Roldan, A. Lopez-Arribas, J. Lozano, M. J. Hernandez-Vidal, I. de la Morena-Barrio, V. Vicente, M. L. Lozano, M. T. Herranz, J. Corral
Publikováno v:
HemaSphere, Vol 6, Pp 1562-1563 (2022)
Externí odkaz:
https://doaj.org/article/d8028890410a405db7821a1069855d21
Autor:
D. Prieto-Peña, J. Loricera, S. Castañeda, C. Moriano, P. Bernabéu, P. Vela-Casasempere, J. Narváez, V. Aldasoro, O. Maíz, C. Fernández-López, M. Freire González, R. Melero, I. Villa-Blanco, B. González-Alvarez, R. Solans-Laqué, J. L. Callejas-Rubio, C. Fernández-Díaz, E. Rubio Romero, S. García Morillo, M. Minguez, C. Fernández-Carballido, E. De Miguel, J. Sanchez-Martin, E. Fernández, S. Melchor, E. Salgado-Pérez, B. Bravo, S. Romero-Yuste, E. Galíndez-Agirregoikoa, F. Sivera, I. Ferraz-Amaro, C. Hidalgo, C. Romero-Gómez, C. Galisteo, P. Moya, N. Alvarez-Rivas, J. Mendizabal, J. C. Nieto González, J. R. De Dios, J. L. Andreu, I. Pérez de Pedro, M. Revenga, J. L. Alonso Valdivieso, R. M. Rosa, I. De la Morena, N. Fernández-Llanio, E. Labrador, J. A. Roman-Ivorra, F. Ortiz-Sanjuán, A. García-Valle, A. Gallego, C. Iñiguez, N. Garrido-Puñal, R. De la Torre, R. López-González, P. Collado, E. Raya, F. Navarro, A. J. Mas, C. Ordás, M. D. Boquet, M. L. Velloso Feijoo, C. Campos Fernández, I. Rúa-Figueroa, A. Conesa, S. Manrique Arija, M. A. González-Gay, R. Blanco
Publikováno v:
Annals of the Rheumatic Diseases. 81:691-692
BackgroundTocilizumab (TCZ) has shown to be effective for large vessel vasculitis including giant cell arteritis (GCA) and Takayasu arteritis (TAK) (1-5). However, LVV-GCA and TAK show different demographic and clinical features that may influence on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8036ee0db76d628f26719c124c11e29
https://doi.org/10.1136/annrheumdis-2022-eular.2330
https://doi.org/10.1136/annrheumdis-2022-eular.2330
Autor:
N. Costas Torrijo, I. De la Morena, D. Bedoya-Sanchis, J. J. Sanmartín Martinez, E. Montesinos Villaescusa, L. Martinez Casimiro, S. Porcar Saura, P. Trenor Larraz
Publikováno v:
Annals of the Rheumatic Diseases. 81:1589.3-1589
BackgroundGuselkumab is a monoclonal antibody against interleukin-23, biological agent approved for the treatment of plaque psoriasis and psoriatic arthritis. There are two randomised, double-blind, placebo-controlled phase III studies (DISCOVER 1 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0484144891225d699624d52ae5e4339d
https://doi.org/10.1136/annrheumdis-2022-eular.5341
https://doi.org/10.1136/annrheumdis-2022-eular.5341
Autor:
S. Vela-Bernal, E. Fuertes, P. Albiol, I. de la Morena, C. Bea, A. I. de Gracia, A. de Castro, L. Navarro, M. J. Forner
Publikováno v:
Annals of the Rheumatic Diseases. 81:1348.1-1348
BackgroundSince 2011, the use of Belimumab for the treatment of Systemic Lupus Erythematosus (SLE)has demonstrated efficacy and safety in several randomised clinical trials. However, strict inclusion criteria may restrict those results limiting the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::111860a75cec29e165aec8c26e80ec42
https://doi.org/10.1136/annrheumdis-2022-eular.3863
https://doi.org/10.1136/annrheumdis-2022-eular.3863
Autor:
J. A. Román Ivorra, I. De la Morena, N. Costas Torrijo, B. Safont, J. Fernández-Melón, B. Nuñez, L. Silva Fernández, L. Cebrián Méndez, L. Lojo, B. López-Muñiz, E. Trallero, M. Lopez Lasanta, R. M. Veiga Cabello, M. D. P. Ahijado Guzman, D. Benavent, D. Vilanova, R. Castellanos Moreira, S. Lujan Valdés
Publikováno v:
Annals of the Rheumatic Diseases. 81:85.1-85
BackgroundInterstitial lung disease (ILD) is one of the most frequent extra-articular manifestations of rheumatoid arthritis (RA) and leads to a significantly increased risk for morbidity and mortality compared with RA alone [1]. The analysis of Elec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9860467852293d0cb9908ac10e0e21ad
https://doi.org/10.1136/annrheumdis-2022-eular.5042
https://doi.org/10.1136/annrheumdis-2022-eular.5042
Autor:
G. Tomas-Cabedo, N. Barrado‐Solís, C. Sanchis‐Sánchez, I. De la Morena‐Barrio, F. Valcuende-Cavero, B. Rodrigo‐Nicolás, G. Perez-Pastor
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73a48db2692a5236826e0d33c87bd0da
https://doi.org/10.1111/jdv.16454
https://doi.org/10.1111/jdv.16454
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Enoc Martinez, Clara Moriano, Susana Romero-Yuste, Roman Blanco, E. Diez, Francisca Sivera, Ignasi Figueras, B. Atienza Mateo, Javier Loricera, I. De la Morena, Gerard Espinosa, T. Pérez Sandoval, F.M. Ortiz Sanjuan, Jenaro Graña, A. Olivé, Ana Isabel Turrión, J. Calvo, Juan José Alegre, José Luis Martín-Varillas, A. Herrero Morant, María Dolores García-Armario, Ivan Castellví, D. Ybáñez-García, JA Román Ivorra, J.A. Narváez, À. Martínez-Ferrer, Pilar Trénor, M. Martín Martínez, Charo Díez, P. Moya Alvarado, A. Pérez Gómez, M. A. González-Gay, Soledad Ojeda, V. Calvo del Rio
Publikováno v:
Annals of the Rheumatic Diseases. 79:841.1-842
Background:Apremilast (APR) has demonstrated efficacy in orogenital ulcers of Behçet´s disease (BD). Response of other clinical manifestations remains unknown.Objectives:To assess the efficacy and safety of APR in monotherapy or combined with disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9f895dc816535db84aa7036646eaa40
https://doi.org/10.1136/annrheumdis-2020-eular.4720
https://doi.org/10.1136/annrheumdis-2020-eular.4720
Autor:
Ignasi Figueras, Susana Romero-Yuste, M. A. González-Gay, Clara Moriano, Soledad Ojeda, Francisca Sivera, Enoc Martinez, Charo Díez, A. Herrero Morant, I. De la Morena, Pilar Trénor, Gerard Espinosa, B. Atienza Mateo, M. Martín Martínez, A. Olivé, F.M. Ortiz Sanjuan, T. Pérez Sandoval, P. Moya Alvarado, J. Calvo, D. Ybáñez-García, A. Pérez Gómez, Javier Loricera, Roman Blanco, E. Diez, María Dolores García-Armario, José Luis Martín-Varillas, J. J. Alegre-Sancho, Ana Isabel Turrión, Adam Prior, Jenaro Graña, Ivan Castellví, JA Román Ivorra, J.A. Narváez, À. Martínez-Ferrer, V. Calvo del Rio, S. Heredia
Publikováno v:
Annals of the Rheumatic Diseases. 79:382.2-382
Background:Apremilast (APR) has demonstrated efficacy in the treatment of oral and/or genital aphthous ulcers in Behçet´s disease (BD). Combination of APR to other disease-modifying anti-rheumatic drugs (DMARDs) has not been assessed.Objectives:To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa0d31c79583530f94671fdbb3f3fcdc
https://doi.org/10.1136/annrheumdis-2020-eular.6246
https://doi.org/10.1136/annrheumdis-2020-eular.6246